Literature DB >> 3932629

Intraperitoneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysis.

S P Andreoli, D Dunn, W DeMyer, D J Sherrard, J M Bergstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3932629     DOI： 10.1016/s0022-3476(85)80412-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  What treatment would you advise for a 1-year-old child with chronic renal failure who has been on aluminum hydroxide as a phosphate binder for 6 months and then develops epilepsy and is found to have a grossly raised plasma aluminum concentration?

Authors:  S P Andreoli; R W Chesney; I B Salusky; A B Sedman
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

2.  Deferoxamine and aluminum clearance in pediatric hemodialysis patients.

Authors:  M R Ogborn; V C Dorcas; J F Crocker
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

3.  Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: association with deferoxamine.

Authors:  M Nakamura; W B Weil; D B Kaufman
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

Review 4.  Recent advances and controversies in childhood renal osteodystrophy.

Authors:  O Mehls; I B Salusky
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

Review 5.  Aluminum toxicity in childhood.

Authors:  A Sedman
Journal:  Pediatr Nephrol       Date:  1992-07       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.